You are here

Compact Line-scanning Adaptive Optics Retinal Imager

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43EY018509-01
Agency Tracking Number: EY018509
Amount: $201,176.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: 2007
Award Year: 2007
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
PHYSICAL SCIENCES INC 20 NEW ENGLAND BUSINESS CENTER
ANDOVER, MA 01810
United States
DUNS: 073800062
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 DANIEL HAMMER
 (978) 689-0003
 HAMMER@PSICORP.COM
Business Contact
Phone: (978) 689-0003
Email: sasso@psicorp.com
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Physical Sciences Inc. (PSI), in consultation with an ophthalmologist from Duke Eye Center, proposes the development of a compact adaptive optics line-scanning laser ophthalmoscope (AO-LSLO). The instrument will greatly reduce the size, cost, and complexity of adaptive optics retinal cameras and lead to more wide-spread use of high-resolution imaging technology by ophthalmologist, optometrist, and vision researchers. In the proposed Phase I program, we will design and model the optical layout, construct a bench-top version of the instrument, and complete a series of experiments to characterize and optimize performance and determine concept feasibility. In a potential Phase II program, we will package the setup into a small housing designed to sit on a slit lamp stage. We will also perform clinical testing on human subjects with retinal diseases at Duke Eye Center in the second half of a Phase II program. The instrument will be amenable to clinical studies for the early detection and progression of retinal disease, direct measurement of the structural and functional characteristics of a wide range of retinal defects, microperimetry and psychophysical vision studies, and for determination of the efficacy of novel genetic and molecular therapies. By making high-resolution ocular access more widespread, the proposed instrument will begin to move adaptive optics technology into a greater number of clinicians and scientists. These researchers will, in turn, use this tool to increase our understanding of vision and its disruption by disease and for the development of new drugs and therapies.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government